[Anti-arrhythmic action of penfenon and clofibrate].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002994:Clofibrate / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D015248:Gemfibrozil / Q000031:analogs & derivatives*; D006880:Hydroxy Acids / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D010421:Pentanoic Acids / Q000627:therapeutic use*; D051381:Rats; D014631:Valerates / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D006880:Hydroxy Acids; D000960:Hypolipidemic Agents; D010421:Pentanoic Acids; D014631:Valerates; C018628:penphenone; D002994:Clofibrate; D015248:Gemfibrozil
O protivoaritmicheskom deĭstvii penfenona i klofibreĭta.